SEC filings
CVS Health (CVS)
Recent filings CVS Health made with the SEC, newest first. Most have a short AI-generated summary, and every one links to the original.
CIK 0000064803All filings on SEC.gov
10-QQuarterly report
Quarterly report
CVS Health announced on Nov. 4, 2026, that it intends to separate into two independent publicly traded companies: a healthcare solutions company comprising Aetna, CVS Caremark, CVS Specialty, Oak Street Health, and Signify Health, and a…
8-KCurrent report
Regulation FD Disclosure
CVS Health announced it intends to separate into two independent publicly traded companies: a healthcare solutions company comprising Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health, to be led by current Chairman…
8-KCurrent report
Results of Operations and Financial Condition
CVS Health reported third quarter 2026 revenues of $108.4 billion, up 5.4% year over year, with GAAP diluted EPS of $1.68 and adjusted EPS of $2.09, and raised its full-year 2026 guidance for GAAP diluted EPS to at least $6.98, adjusted…
8-KCurrent report
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Regulation FD Disclosure
CVS Health announced the resignation of Larry M. Robbins from its Board of Directors and the appointment of Teresa Heitsenrether, who currently serves as Executive Vice President and Chief Data & Analytics Officer of JPMorgan Chase & Co.…
10-QQuarterly report
Quarterly report
CVS Health's second-quarter 2026 results show total revenues of $106.1 billion, up 7.3% from a year earlier, and net income attributable to CVS Health of $2.98 billion, up 191.8%, aided by the absence of $833 million in legacy litigation…
8-KCurrent report
Results of Operations and Financial Condition
It reported second-quarter 2026 total revenues of $106.1 billion, up 7.3% year-over-year, with GAAP diluted EPS of $2.31 and adjusted EPS of $2.58, and raised its full-year 2026 guidance for GAAP diluted EPS to $6.84–$7.04, adjusted EPS to…
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.
Follow CVS Health in Readster
Add CVS Health to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.
No credit card. When the trial ends, you move to Readster Free unless you subscribe.